Showing 431-440 of 5956 results for "".
Learn How Vitamin A Supports the Ocular Surface
https://modernod.com/podcasts/to-the-point/learn-how-vitamin-a-supports-the-ocular-surface/36944/Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MS, MBA, FAAO, have a conversation with Kaleb Abbott, OD, FAAO, on the importance of vitamin A in maintaining ocular surface health. Dr. Abbott discusses the various forms of vitamin A, where it can be obtained, settings in which it can be potentiallGame-Changing Tools That Could Improve Your Practice
https://modernod.com/videos/eye-care-insiders/eye-care-insiders-july-2024-video/37346/Joseph J. Allen, OD, FAAO, Dipl ABO, shares his review of several new eye care-related tools, technologies, and devices he learned about and tested out at recent optometry meetings and conferences. He explains what they are designed to do, specific advantages they offer to expand your diagnostic capPractical Advice for Defining Your Brand on Social Media
https://modernod.com/videos/eye-care-insiders/eye-care-insiders-may-video-2024/37344/Joseph J. Allen, OD, FAAO, Dipl ABO, is host to several successful online channels in addition to Eye Care Insiders, and in this episode, he offers seven tips for creating or jumpstarting a practice’s social media presence. Drawing on years of experience with creating content for various audiences,Keep Autoimmune Rheumatic Disease On Your DED Radar
https://modernod.com/podcasts/the-mod-pod/keep-autoimmune-rheumatic-disease-on-your-ded-radar/56396/Here’s what to look out for—and how to proceed if you find it.Update on Investigational Treatments for Retinal Diseases
https://modernod.com/podcasts/eyewire-news-the-podcast/update-on-investigational-treatments-for-retinal-diseases/39869/Several companies with treatment candidates for retinal diseases provide clinical updates; Nicox releases new phase 3 data for its investigational glaucoma eye drop; the first patient is implanted with Ocumetics’ novel accommodating lens; and ASCRS provides details for its second annual Business ofCE Certification for New Glaucoma Surgical Implant
https://modernod.com/podcasts/eyewire-news-the-podcast/ce-certification-for-new-glaucoma-surgical-implant/39868/Ciliatech obtains CE certification for the Intercil Uveal Spacer surgical implant; Zeiss receives CE mark for a new device that uses AI to automate OCT assessment; and the FDA extends the target action dates for two Eylea HD submissions. Learn more about your ad choices. Visit megaphone.fm/adchoicAlcon Launches PanOptix Pro in US
https://modernod.com/podcasts/eyewire-news-the-podcast/alcon-launches-panoptix-pro-in-us/37078/Alcon introduces its next-generation trifocal IOL; Alcon announces a deal to advance its clinical-stage allogeneic cell therapy; and Bausch + Lomb announces a voluntary recall of IOLs on its enVista platform. Learn more about your ad choices. Visit megaphone.fm/adchoicesFDA Expands Product Label for Iluvien
https://modernod.com/podcasts/eyewire-news-the-podcast/fda-expands-product-label-for-iluvien/37076/Iluvien receives a major label expansion; Bausch and Lomb launches a new orthokeratology lens fitting system; and several updates are announced in development wet AMD candidates. Learn more about your ad choices. Visit megaphone.fm/adchoices88. Decoding Headaches: When Vision is the Culprit
https://modernod.com/podcasts/four-eyes/88-decoding-headaches-when-vision-is-the-culprit/37038/Headaches are one of the most common patient complaints—but how do you know if they’re vision-related? In this episode, Dr. Kar and Dr. Bilkhu break down different types of headaches, key signs that point to a visual cause, and when to refer for urgent medical attention. We also dive into treatmentAlcon Voyager DSLT Fully Launched in US
https://modernod.com/podcasts/eyewire-news-the-podcast/alcon-voyager-dslt-fully-launched-in-us/37072/Alcon launches the first DSLT device in thee US; the FDA approves an expanded label for Astellas Pharma's geographic atrophy drug Izervay; and New World Medical received FDA clearance for the VIA360 Surgical System. Learn more about your ad choices. Visit megaphone.fm/adchoices